ReviewClinical drug investigation2020

Performance-Based Risk-Sharing Arrangements (PBRSA): Is it a Solution to Increase Bang for the Buck for Pharmaceutical Reimbursement Strategy for Our Nation and Around the World?

Andy Eunwoo Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.